Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study

H. Joensuu; F. De Braud; G. Grignagni; T. De Pas; G. Spitalieri; P. Coco; C. Spreafico; S. Boselli; F. Toffalorio; P. Bono; T. Jalava; C. Kappeler; M. Aglietta; D. Laurent; P. G. Casali

doi:10.1038/bjc.2011.151

Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study

H. Joensuu
, F. De Braud
, G. Grignagni
, T. De Pas
, G. Spitalieri
, P. Coco
, C. Spreafico
, S. Boselli
, F. Toffalorio
, P. Bono
, T. Jalava
, C. Kappeler
, M. Aglietta
, D. Laurent
, P. G. Casali

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	British Journal of Cancer
Volym	104
Nummer	11
Sidor (från-till)	1686-1690
Antal sidor	5
ISSN	0007-0920
DOI	https://doi.org/10.1038/bjc.2011.151
Status	Publicerad - 2011
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3122 Cancersjukdomar

Åtkomst av dokument

10.1038/bjc.2011.151

Citera det här

Joensuu, H., De Braud, F., Grignagni, G., De Pas, T., Spitalieri, G., Coco, P., Spreafico, C., Boselli, S., Toffalorio, F., Bono, P., Jalava, T., Kappeler, C., Aglietta, M., Laurent, D., & Casali, P. G. (2011). Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study. British Journal of Cancer, 104(11), 1686-1690. https://doi.org/10.1038/bjc.2011.151

@article{439e28a1dfd74cf386210c5f5f46db97,

title = "Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study",

keywords = "gastrointestinal stromal tumour, vatalanib, imatinib, sunitinib, tyrosine kinase inhibitor, targeted therapy, DOSE IMATINIB, MESYLATE, INHIBITOR, MUTATIONS, SAFETY, TRIAL, KIT, 3122 Cancers",

author = "H. Joensuu and \{De Braud\}, F. and G. Grignagni and \{De Pas\}, T. and G. Spitalieri and P. Coco and C. Spreafico and S. Boselli and F. Toffalorio and P. Bono and T. Jalava and C. Kappeler and M. Aglietta and D. Laurent and Casali, \{P. G.\}",

year = "2011",

doi = "10.1038/bjc.2011.151",

language = "English",

volume = "104",

pages = "1686--1690",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Springer",

number = "11",

}

Joensuu, H, De Braud, F, Grignagni, G, De Pas, T, Spitalieri, G, Coco, P, Spreafico, C, Boselli, S, Toffalorio, F, Bono, P, Jalava, T, Kappeler, C, Aglietta, M, Laurent, D & Casali, PG 2011, 'Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study', British Journal of Cancer, vol. 104, nr. 11, s. 1686-1690. https://doi.org/10.1038/bjc.2011.151

TY - JOUR

T1 - Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study

AU - Joensuu, H.

AU - De Braud, F.

AU - Grignagni, G.

AU - De Pas, T.

AU - Spitalieri, G.

AU - Coco, P.

AU - Spreafico, C.

AU - Boselli, S.

AU - Toffalorio, F.

AU - Bono, P.

AU - Jalava, T.

AU - Kappeler, C.

AU - Aglietta, M.

AU - Laurent, D.

AU - Casali, P. G.

PY - 2011

Y1 - 2011

KW - gastrointestinal stromal tumour

KW - vatalanib

KW - imatinib

KW - sunitinib

KW - tyrosine kinase inhibitor

KW - targeted therapy

KW - DOSE IMATINIB

KW - MESYLATE

KW - INHIBITOR

KW - MUTATIONS

KW - SAFETY

KW - TRIAL

KW - KIT

KW - 3122 Cancers

U2 - 10.1038/bjc.2011.151

DO - 10.1038/bjc.2011.151

M3 - Article

SN - 0007-0920

VL - 104

SP - 1686

EP - 1690

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 11

ER -